Kelsie L. Becklin

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma”.

Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0369

N/A

0.416DataRank · unranked

15 citations

Garrett M. Draper, Nicholas J. Slipek, Alex T. Larsson, Natalie Stratton, Emily J. Pomeroy +14 more

Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy

Frontiers in Cell and Developmental Biology(2022)10.3389/fcell.2022.894635

N/A

0DataRank · unranked

29 citations

Kelsie L. Becklin, Sophie Givens, Elizabeth R. Komosa, Juan E. Abrahante, Forum Kamdar +5 more

Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.05.487211

N/A

0DataRank · unranked

1 citations

Kelsie L. Becklin, Sophie Givens, Elizabeth R. Komosa, Juan E. Abrahante, Forum Kamdar +5 more